NIH Center for Regenerative Medicine (NIH CRM)

Science Publications


 
Public private partnerships: A marriage of necessity
Rao M
Cell Stem Cell. 2013 Feb 7. 149-51 
PMID: 23395442 [PubMed]
Transgene-free iPSCs generated from small volume peripheral blood non-mobilized CD34+ cells
Merling RK, Sweeney CL, Choi U, De Ravin SS, Myers TG, Otaizo-Carrasquero F, Pan J, Linton G, Chen L, Koontz S, Theobald NL, Malech HL
Blood. 2013 Feb 5. [Epub ahead of print] 
PMID: 23386128 [PubMed]
Applications of quantitative polymerase chain reaction protein assays during reprogramming
Ruff D, MacArthur C, Tran H, Bergseid J, Tian J, Shannon M, Chen SM, Fontes A, Laurent L, Swartzman E, Taliana A, Rao M, Lieu PT
Stem Cells Dev. 2012 Mar. 530-8 
PMID: 21476854 [PubMed]
Human Schwann cells retain essential phenotype characteristics after immortalization
Lehmann HC, Chen W, Mi R, Wang S, Liu Y, Rao M, Hoke A
Stem Cells Dev. 2012 Feb. 423-31 
PMID: 21585251 [PubMed]
Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus
Macarthur CC, Xue H, Van Hoof D, Lieu PT, Dudas M, Fontes A, Swistowski A, Touboul T, Seerke R, Laurent LC, Loring JF, German MS, Zeng X, Rao MS, Lakshmipathy U, Chesnut JD, Liu Y
Stem Cells Dev. 2012 Jan. 191-205 
PMID: 21699412 [PubMed]
Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology
Gundry RL, Burridge PW, Boheler KR
Proteomics. 2011 Oct. 3947-61 
PMID: 21834136 [PubMed]
Concise review: Non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency
Parameswaran S, Balasubramanian S, Rao MS, Ahmad I
Stem Cells. 2011 Jul. 1013-20 
PMID: 21544901 [PubMed]
Funding translational work in cell-based therapy
Rao MS
Cell Stem Cell. 2011 Jul. 7-10 
PMID: 21726828 [PubMed]
Seeing is believing: Are cancer stem cells the Loch Ness monster of tumor biology?
Lathia JD, Venere M, Rao MS, Rich JN
Stem Cell Rev. 2011 Jun. 227-37 
PMID: 20957452 [PubMed]
Keeping things simple
Rao M
Nature Methods. 2011 May. 389-90 
PMID: 21527929 [PubMed]
Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: Functional correction by zinc finger nuclease-mediated safe harbor targeting
Zou J, Sweeney CL, Chou BK, Choi U, Pan J, Wang H, Dowey SN, Cheng L, Malech HL
Blood. 2011 May. 5561-72 
PMID: 21411759 [PubMed]
Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells
Juan AH, Derfoul Z, Feng X, Ryall JG, Dell’Orso S, Pasut A, Zare H, Simone JM, Rudnicki MA, Sartorelli V
Genes Dev. 2011 April. 789-94 
PMID: 21498568 [PubMed]
The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells
Bharti K, Miller SS, Arnheiter H
Pigment Cell Melanoma Res. 2011 Feb. 21-34 
PMID: 20846177 [PubMed]
Mesenchymal stem cell assays and applications
Vemuri MC, Chase LG, Rao MS
Methods Mol Biol. 2011. 3-8 
PMID: 21431506 [PubMed]



  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer
Division of Program Coordination, Planning, and Strategic Initiatives  •  National Institutes of Health  •  Bethesda, Maryland 20892